For: | Sieben M, Herzer K, Zeidler M, Heinrichs V, Leuchs B, Schuler M, Cornelis JJ, Galle PR, Rommelaere J, Moehler M. Killing of p53-deficient hepatoma cells by parvovirus H-1 and chemotherapeutics requires promyelocytic leukemia protein. World J Gastroenterol 2008; 14(24): 3819-3828 [PMID: 18609705 DOI: 10.3748/wjg.14.3819] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v14/i24/3819.htm |
Number | Citing Articles |
1 |
Kan Lu, Yonglong Pan, Zhao Huang, Huifang Liang, Ze-yang Ding, Bixiang Zhang. TRIM proteins in hepatocellular carcinoma. Journal of Biomedical Science 2022; 29(1) doi: 10.1186/s12929-022-00854-7
|
2 |
Rong-Hua Tao, Zuzana Berkova, Jillian F. Wise, Abdol-Hossein Rezaeian, Urszula Daniluk, Xue Ao, David H. Hawke, Judith E. Karp, Hui-Kuan Lin, Jeffrey J. Molldrem, Felipe Samaniego. PMLRARα binds to Fas and suppresses Fas-mediated apoptosis through recruiting c-FLIP in vivo. Blood 2011; 118(11): 3107 doi: 10.1182/blood-2011-04-349670
|
3 |
Markus Moehler, Maike Sieben, Susanne Roth, Franziska Springsguth, Barbara Leuchs, Maja Zeidler, Christiane Dinsart, Jean Rommelaere, Peter R Galle. Activation of the human immune system by chemotherapeutic or targeted agents combined with the oncolytic parvovirus H-1. BMC Cancer 2011; 11(1) doi: 10.1186/1471-2407-11-464
|
4 |
Jürg P. F. Nüesch, Jean Rommelaere. Anticancer Genes. Advances in Experimental Medicine and Biology 2014; 818: 99 doi: 10.1007/978-1-4471-6458-6_5
|
5 |
Jennifer Altomonte, Oliver Ebert. Sorting Out Pandora’s Box: Discerning the Dynamic Roles of Liver Microenvironment in Oncolytic Virus Therapy for Hepatocellular Carcinoma. Frontiers in Oncology 2014; 4 doi: 10.3389/fonc.2014.00085
|
6 |
Antonio Marchini, Serena Bonifati, Eleanor M Scott, Assia L Angelova, Jean Rommelaere. Oncolytic parvoviruses: from basic virology to clinical applications. Virology Journal 2015; 12(1) doi: 10.1186/s12985-014-0223-y
|
7 |
Kathryn Ottolino-Perry, Jean-Simon Diallo, Brian D Lichty, John C Bell, J Andrea McCart. Intelligent Design: Combination Therapy With Oncolytic Viruses. Molecular Therapy 2010; 18(2): 251 doi: 10.1038/mt.2009.283
|
8 |
Michal Mincberg, Jacob Gopas, Jacov Tal. Minute virus of mice (MVMp) infection and NS1 expression induce p53 independent apoptosis in transformed rat fibroblast cells. Virology 2011; 412(1): 233 doi: 10.1016/j.virol.2010.12.035
|
9 |
Jürg P.F. Nüesch, Jeannine Lacroix, Antonio Marchini, Jean Rommelaere. Molecular Pathways: Rodent Parvoviruses—Mechanisms of Oncolysis and Prospects for Clinical Cancer Treatment. Clinical Cancer Research 2012; 18(13): 3516 doi: 10.1158/1078-0432.CCR-11-2325
|
10 |
Svenja Sydor, Paul Manka, Jan Best, Sami Jafoui, Jan-Peter Sowa, Miguel Eugenio Zoubek, Virginia Hernandez-Gea, Francisco Javier Cubero, Julia Kälsch, Diana Vetter, Maria Isabel Fiel, Yujin Hoshida, C. Billie Bian, Leonard J. Nelson, Han Moshage, Klaas Nico Faber, Andreas Paul, Hideo A. Baba, Guido Gerken, Scott L. Friedman, Ali Canbay, Lars P. Bechmann. Krüppel-like factor 6 is a transcriptional activator of autophagy in acute liver injury. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-08680-w
|
11 |
Pierre Garcin, Sarah Cohen, Sanne Terpstra, Isabelle Kelly, Leonard J. Foster, Nelly Panté. Proteomic analysis identifies a novel function for galectin-3 in the cell entry of parvovirus. Journal of Proteomics 2013; 79: 123 doi: 10.1016/j.jprot.2012.12.010
|
12 |
Vikrant Rai, Joe Abdo, Abdullah N. Alsuwaidan, Swati Agrawal, Poonam Sharma, Devendra K. Agrawal. Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma. Molecular and Cellular Biochemistry 2018; 437(1-2): 13 doi: 10.1007/s11010-017-3092-z
|
13 |
Maike Delic, Veronika Boeswald, Katrin Goepfert, Petra Pabst, Markus Moehler. In vitro Characterization of Enhanced Human Immune Responses by GM-CSF Encoding HSV-1-Induced Melanoma Cells. OncoTargets and Therapy 2022; : 1291 doi: 10.2147/OTT.S350136
|